{"transactions":[{"id":1708766,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96123,"kind":"person","name":"Liu Hui","position":1,"cik":"0001834660","reported_name":"Liu Hui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2023-12-16T02:46:20.000Z","date":"2023-12-15","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 15, 2024 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2024."}],"balance_after":1000000,"derivative":{"exercise_price":0.247,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001493152-23-045172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315223045172/ownership.xml","form_type":"4"}},{"id":2077377,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96123,"kind":"person","name":"Liu Hui","position":1,"cik":"0001834660","reported_name":"Liu Hui","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2022-12-22T16:23:45.000Z","date":"2022-12-20","kind":"grant","acquired":true,"shares":625000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 20, 2023 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2023."}],"balance_after":625000,"derivative":{"exercise_price":0.53,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":625000},"source":{"system":"sec-edgar","filing":"0001493152-22-036240","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315222036240/ownership.xml","form_type":"4"}},{"id":2471214,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96123,"kind":"person","name":"Liu Hui","position":1,"cik":"0001834660","reported_name":"Hui Liu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to Buy)","published_at":"2021-12-16T02:24:19.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 14, 2022 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2022."}],"balance_after":275000,"derivative":{"exercise_price":0.92,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000905718-21-001611","document":"matinas_fm4dec142021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000090571821001611/matinas_fm4dec142021.xml","form_type":"4"}},{"id":2924949,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96123,"kind":"person","name":"Liu Hui","position":1,"cik":"0001834660","reported_name":"Hui Liu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-01-04T23:30:12.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on January 1, 2022 with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on February 1, 2022."}],"balance_after":250000,"derivative":{"exercise_price":1.36,"expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-21-000134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315221000134/ownership.xml","form_type":"4"}},{"id":2957660,"issuer":{"id":8443,"kind":"organization","name":"Matinas BioPharma Holdings, Inc."},"owners":[{"id":96123,"kind":"person","name":"Liu Hui","position":1,"cik":"0001834660","reported_name":"Hui Liu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-12-03T21:08:54.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the \"2013 Plan\"). The option vests as to 25% on December 1, 2021, thereafter the remaining options vest in equal monthly installments over a period of 36 months commencing on January 1, 2022."}],"balance_after":350000,"derivative":{"exercise_price":1.07,"expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001493152-20-022913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582554/000149315220022913/ownership.xml","form_type":"4"}}]}